Tedla Yacob G, Bautista Leonelo E
Department of Preventive Medicine, Northwestern University, Chicago, Illinois, USA;
Department of Population Health Sciences, University of Wisconsin at Madison, Madison, Wisconsin, USA.
Am J Hypertens. 2016 Jun;29(6):772-9. doi: 10.1093/ajh/hpv185. Epub 2015 Dec 7.
Non-adherence to antihypertensive medication increases the risk of uncontrolled hypertension. Antihypertensive drug-related symptoms (side effects) are frequently cited as a main cause of non-adherence, but with little support from prospective studies. We evaluated the association between drug side effects and prospective adherence to treatment.
We collected data on the number and dose of antihypertensive drugs at enrollment and at 3, 6, 9, and 12 months of follow-up in a cohort of 175 hypertensive patients starting or restarting antihypertensive treatment (mean age: 50 years; 58% women). During the follow-up visits, we gathered data on 24 side effects during the last month and the pill count adherence ratio (PCAR = pills taken out of number prescribed × 100) since the previous visit. The association between side effects at a visit and adherence through the next visit was estimated using mixed effect models.
Eighty-five percent of the participants experienced side effects, and 34.5% became non-adherent (PCAR <80%). After adjusting for confounders, PCAR was 6.0 percentage points lower (P = 0.04) among individuals with number of side effects above the median value (4 symptoms). Also, in individuals with genitourinary side effects, PCAR was 7.1 percentage points lower (P = 0.02) than in those without such side effects. Specifically, PCAR was 6.5 (P = 0.06) and 7.6 (P = 0.01) percentage points lower among individuals with excessive urination and decrease in sexual drive, respectively.
Antihypertensive drug side effects was associated with drug adherence but only excessive urination and decrease in sexual drive significantly predicted lower adherence. These symptoms could be used as markers to screen out patients at high risk of non-adherence.
不坚持服用抗高血压药物会增加高血压控制不佳的风险。抗高血压药物相关症状(副作用)常被认为是不坚持服药的主要原因,但前瞻性研究对此支持甚少。我们评估了药物副作用与前瞻性治疗依从性之间的关联。
我们收集了175例开始或重新开始抗高血压治疗的高血压患者(平均年龄:50岁;58%为女性)入组时以及随访3、6、9和12个月时抗高血压药物的数量和剂量数据。在随访期间,我们收集了过去一个月内24种副作用的数据以及自上次就诊以来的药丸计数依从率(PCAR = 实际服用药丸数/处方规定药丸数×100)。使用混合效应模型估计就诊时的副作用与下次就诊时的依从性之间的关联。
85%的参与者出现了副作用,34.5%的人变得不依从(PCAR <80%)。在调整混杂因素后,副作用数量高于中位数(4种症状)的个体的PCAR低6.0个百分点(P = 0.04)。此外,有泌尿生殖系统副作用的个体的PCAR比没有此类副作用的个体低7.1个百分点(P = 0.02)。具体而言,多尿和性欲减退的个体的PCAR分别低6.5个百分点(P = 0.06)和7.6个百分点(P = 0.01)。
抗高血压药物副作用与药物依从性相关,但只有多尿和性欲减退显著预测较低的依从性。这些症状可作为筛选出不依从高风险患者的标志物。